ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $58 | -40.8% | 36,699 | +133.0% | 0.01% | -50.0% |
| Q4 2022 | $98 | -99.9% | 15,753 | +1.0% | 0.01% | +25.0% |
| Q1 2022 | $72,000 | -13.3% | 15,598 | -5.9% | 0.01% | -11.1% |
| Q4 2021 | $83,000 | -79.2% | 16,570 | +93.1% | 0.01% | -86.6% |
| Q2 2019 | $399,000 | +21.3% | 8,580 | +4.8% | 0.07% | +24.1% |
| Q1 2019 | $329,000 | -53.5% | 8,190 | -42.0% | 0.05% | -53.0% |
| Q3 2017 | $707,000 | – | 14,110 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |